Items tagged with Drug-resistant TB
Final STREAM Stage 1 trial results published (post)
The final results from the STREAM Stage 1 trial, which compared 9-11 months of standardized treatment using older drugs (the so-called modified "Bangladesh" regimen) to the 2011 World Health Organization (WHO)-recommended treatment, were published in the New England Journal of Medicine.
WHO/Europe: New expert group on DR-TB to support more and better national research for treatment of resistant forms of TB (post)
WHO has facilitated the creation of a new expert group on drug-resistant tuberculosis (DR-TB) to support Member States in improving their research on treatment. The areas of focus of the group, part of the WHO European Tuberculosis Research Initiative (ERI-TB), were agreed at a planning meeting in Vienna, Austria, on 22 February 2019.
UN approves five sanctions exemptions for humanitarian aid to North Korea (post)
Approval sees return of Médecins Sans Frontières (MSF) to North Korea after four-year absence.
India should heed a teenager’s historic fight for lifesaving TB treatment (post)
Malala Yousafzai and Greta Thunberg have shown us the formidable power of a single adolescent girl with determination. Shreya Tripathi of India, who didn’t live to see her 20th birthday, belongs with Malala and Greta in the pantheon of teenagers whose unswerving principles have brought the powerful to their knees.
Belarus to switch to WHO’s new treatment guidelines for MDR-TB (post)
“The World Health Organization has recently updated its treatment guidelines for multidrug-resistant tuberculosis (MDR-TB). Now all MDR-TB patients (not only those with extensively drug-resistant tuberculosis, XDR-TB) should get new medicines in line with the WHO's new recommendations,” Vyacheslav Grankov, Communicable Diseases Programme Coordinator of the World Health Organization in Belarus, said.
South Africa: Drug-resistant TB hard to root out (post)
WORLD TB DAY: Although South Africa has the highest per capita burden of drug-resistant TB in the world, there are many barriers to addressing this – as one patient found out when it took doctors two years to diagnose him.
SFU-led team fights drug-resistant TB with artificial intelligence (post)
Tuberculosis (TB) is the world’s deadliest infectious killer but a team of SFU-led researchers is determined to fight it—using artificial intelligence.
Unitaid and Japan move to align their efforts against TB (post)
Tokyo, 2 April 2019 — Unitaid Executive Director Lelio Marmora and Parliamentary Vice-Minister for Foreign Affairs of Japan Kenji Yamada met today to discuss a new alignment between Japan’s global health priorities and Unitaid’s work in fighting tuberculosis.
TB killed Shreya Tripathi, but her death could have been avoided (post)
India's health ministry wanted to distribute a life saving TB drug only to patients in big cities. A girl from Patna fought the government and won, but it was too late for her.
Shorter treatments transform lives of TB patients in Kyrgyzstan (post)
Kyrgyzstan is one of 30 countries in the world with high rates of drug-resistant TB – 26 per cent of new cases of TB are drug resistant, compared to a world average of four per cent. And a staggering 61 per cent of reinfections are the drug resistant form, compared to 19 per cent globally.
Page 58 of 117 · Total posts: 0
←First 57 58 59 Last→